Synopsis
MASSIF-3 is a minifocus beamline (15 µm diameter), operating at fixed energy (12.81 keV). The beamline is dedicated to protein crystals of small size, inhomogeneous protein crystals, and fast data collection, and is also suitable for SAD measurements (Se, Pt, Au,...). MASSIF-3 is equipped with a MD2 micro-diffractometer and with a FlexHCD sample changer for SPINE pucks and UniPucks. Diffraction data are recorded on an Eiger1 X 4M detector that allows data collection at a very high frame rate (up to 750 Hz). The high resolution limit on the beamline is 1.17 Å.
Status:
open
Disciplines
- Medicine
- Life Sciences
- Chemistry
- Environmental Sciences
Applications
- Macromolecular crystallography
- Time resolved serial oscillation crystallography (SOX)
Techniques
-
Anomalous diffraction
-
MX - macromolecular crystallography
-
Microbeam
-
Microcrystallography
-
Optical spectroscopy
-
Single-crystal diffraction
-
XRD - X-ray diffraction
Beam size
- Minimum (H x V) : 15.0
x 15.0
µm²
-
Maximum (H x V) : 15.0
x 15.0
µm²
Sample environments
- 100 K cryostream
- automatic sample changer
- dehydration device
- online microspec
Detectors
Technical details
High resolution limit - 1.17Å
References:
ID30A-3 (MASSIF-3) – a beamline for macromolecular crystallography at the ESRF with a small intense beam, D. Von Stetten et al., J. Synchrotron Radiat. (2020) 27: 844–851. doi: 10.1107/S1600577520004002
The Upgrade Programme for the Structural Biology beamlines at the European Synchrotron Radiation Facility – High throughput sample evaluation and automation, P. Theveneau et al. (2013) J. Phys.: Conf. Ser. 425 012001 doi:10.1088/1742-6596/425/1/012001
Structural and binding studies of the mycobacterial heat shock protein reveal a silent state and offer insights into dendritic cell activation
Barra G., Sala M., Scala M.C., Campiglia P., Kim H.J., Ruggiero A., Berisio R.,
International Journal of Biological Macromolecules 353, 151218-1-151218-11 (2026)
Exploring dual inhibitors Carbonic Anhydrases and Phosphodiesterase 5 as potential agents for treatment Alzheimer's disease
Costa A., Provensi G., Titi C., Leri M., Bucciantini M., Ferraroni M., Keeton A.B., Moore A.M., Piazza G.A., Abadi A.H., Angeli A., Supuran C.T.,
European Journal of Medicinal Chemistry 303, 118404-1-118404-18 (2026)
Novel fluoro-brominated benzotriazoles as potential CK2 inhibitors. How does fluorination affect the properties of benzotriazoles?
Kasperowicz S., Werner C., Podsiadla-Bialoskórska M., Szolajska E., Maciejewska A.M., Lindenblatt D., Niefind K., Poznanski J., Winiewska-Szajewska M.,
Bioorganic Chemistry 169, 109446-1-109446-14 (2026)
Catalytic pKa attenuation in a hydrolytic metalloenzyme by genetic code expansion
Manser B.P., Liang A.D.,
Biochemistry 65, 559-570 (2026)
Molecular and structural basis for nitrosoglutathione-dependent redox regulation of triosephosphate isomerase from Chlamydomonas reinhardtii
Meloni M., Mattioli E.J., Fanti S., Peppi G.M.E., Bin T., Gabellini G., Tedesco D., Henri J., Trost P., Lemaire S.D., Calvaresi M., Fermani S., Zaffagnini M.,
Plant Science 362, 112768-1-112768-12 (2026)
Structural basis of quinone sensing by the MarR-type repressor MhqR in Staphylococcus aureus
Nguyen T.T.P., Weiland P., Loi V.V., Kiontke S., Burchert F., Zegarra V., Kern A., Fritsch V.N., Baranov D., Bronowska A.K., Bange G., Antelmann H.,
mBio 17, 03292-25-1-03292-25-23 (2026)